AUTOLUS THERAPEUTICS PLC - AMERICAN DEPOSITARY SHA

Autolus Therapeutics to Present New Data on AUTO1 in r/r Indolent B Cell Lymphomas at the European Hematology Association Virtual Congress

12 مايو 2021 10:00:00 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics Reports First Quarter 2021 Financial Results and Operational Progress

06 مايو 2021 07:00:02 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics to Report First Quarter 2021 Financial Results and Host Conference Call on May 6

26 أبريل 2021 07:00:01 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics Receives Innovation Passport and entry into ILAP for AUTO4 for the treatment of T cell receptor constant region beta chain 1 (TRBC1) positive T cell lymphomas

20 أبريل 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics announces appointment of Martin Murphy as Non-executive Chairman

19 أبريل 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics to Participate in Investor Conferences Through April

01 أبريل 2021 16:01:00 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics Receives PRIME designation for AUTO1 for the treatment of adult ALL

01 أبريل 2021 08:45:42 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics Announces Updated Manufacturing Facility Strategy Leveraging its UK Operations

29 مارس 2021 08:00:00 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Progress

04 مارس 2021 07:00:01 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference

24 فبراير 2021 07:00:01 بحسب Nasdaq GlobeNewswire

Autolus Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional ADSs

12 فبراير 2021 16:01:00 بحسب Nasdaq GlobeNewswire

Autolus Announces Pricing of Public Offering

09 فبراير 2021 20:42:36 بحسب Nasdaq GlobeNewswire

Autolus Announces Proposed Public Offering in the United States

08 فبراير 2021 16:18:56 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on March 4

04 فبراير 2021 07:00:01 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics provides business outlook for 2021 & 2022

06 يناير 2021 04:07:15 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics to participate in Investor Conferences through January

04 يناير 2021 07:00:00 بحسب Nasdaq GlobeNewswire